Close Menu

NEW YORK – Becton Dickinson said on Wednesday that it began offering $1.5 billion of common stock and $1.5 billion of depositary shares. The firm plans to use the proceeds for general corporate purposes.

Joint book-running managers for the offerings are J.P. Morgan, Barclays, and Goldman Sachs.

In a statement, BD said that the common stock has a par value of $1 per share, and the depository shares represent 1/20th interest in its mandatory convertible preferred stock, par value $1 per share, Series B.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Independent advisors to the US Food and Drug Administration are to meet this week to discuss how they will make SARS-CoV-2 vaccine recommendations, the Washington Post reports.

The New York Times reports on how the US Food and Drug Administration has attempted to gird against pressure from the White House.

Researchers have identified a gene involved in how people determine when to urinate.

In Genome Research this week: assay for profiling chromatin accessibility, analysis of genetic variants among malaria-transmitting mosquitoes, and more.